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Summary Dietary supplementation with extract of fruit of Emblica officinalis Gaertn. (a rich source of vitamin C) to mice in vivo significantly
reduced the cytotoxic effects of a known carcinogen, 3,4-benzo(a)pyrene. Age-matched Swiss albino mice were fed by gavaging the fruit
extract daily for 28 days. From day 9, one dose of the carcinogen was given on alternate days up to a total of eight doses. On day 29, all mice
were transferred to normal diet. Control sets received the extract alone, the carcinogen alone and olive oil alone. All mice were sacrificed at
12 weeks and 14 weeks after the end of the experiment. Chromosome preparations were made from bone marrow after the usual
colchicine-hypotonic-fixative-air drying-Giemsa staining schedule. Cytogenetic end points screened were the frequencies of chromosomal
aberrations and of damaged cells induced. The cytotoxic effects were significantly lower in the mice given the fruit extract with the carcinogen
than in those given the carcinogen alone.
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Epidemiological studies indicate a negative association between
the consumption of diets rich in fibre, fresh vegetables, vitamins,
minerals, etc. and carcinogenesis (Archer, 1988; Birt and
Bresnick, 1991). Of the different plant products found to reduce
the toxic effects of known carcinogens, mutagens and clastogens,
fruits of Emblic myroblan or Emblica officinalis Gaertn.
(=Phyllanthus emblica L.) of the family Euphorbiaceae and its
related species are used extensively in systems oftraditional medi-
cine in India for the treatment of a variety of diseases, including
scurvy (Chopra et al, 1956), ulceration (Gupta, 1908) and leucor-
rhoea (Rao et al, 1985). The fruits contain a high amount of
vitamin C. Extracts ofcertain plant parts, when tested on different
living systems, have been observed to be able to protect against the
mutagenic activity ofknown genotoxicants (Barale et al, 1983; Ito
et al, 1986; Muenzner, 1986; Kim et al, 1987; Hayatsu et al, 1988;
Sharma, 1990; Roy et al, 1991). The fruit extract ofEmblica offic-
inalis has also been shown to significantly reduce the clastogenic
effects of a number of metals (Giri and Banerjee, 1986; Dhir et al,
1990a and b). Vitamin C itself inhibits the nitrosation reaction
(Bartsch et al, 1988) and the formation of N-nitroso compounds,
suggesting a possible use in chemoprevention ofcancer associated
with nitrosation (Licht et al, 1988). Earlier, we had observed that
when mice were given the extract of Emblica officinalis fruit by
gavaging in vivo daily, the clastogenic activity of several metallic
compounds, such as Cr, Pb, Co and Ni, was significantly reduced.
The reduction was significant, after both acute and chronic
exposure to the genotoxicants, in animals given the extracts daily
before and during the exposure (Dhir et al, 1990a, 1991, 1993;
Roy et al, 1992, for review see Sharma, 1995).
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The present investigation was undertaken to find out the
chemoprevention afforded by prolonged dietary supplementation
with a crude extract of the fruit against exposure to 3,4-
benzo(a)pyrene, which is a well known carcinogen and clastogen
(Kliesch et al, 1982).
MATERIALS AND METHODS
Preparation of chemopreventive agent
The average daily intake of vitamin C (ascorbic acid) by an adult
human of body weight 60 kg is 500 mg (reviewed in Davies et al,
1991) giving a value of 8.33 mg kg-1 body weight. The amount of
ascorbic acid present in the dried fruit extract ofEmblica officinalis
Gaertn. was estimated using the 2,6-dichlorophenol-indophenol
method (Pearson, 1952). Ofthe dried fruit, 685 mg was crushed in
20 ml of distilled water, soaked overnight and strained through a
fine muslin cloth. The amount of ascorbic acid in the extract was
equivalent to the human intake (Ghosh, 1991).
The average composition of the fruit pulp is moisture, 81.2%;
protein, 0.5%; fat, 0.1%; mineral matter, 0.7%; fibre, 3.4%; carbo-
hydrates, 14.1%; calcium, 0.05%; phosphorus, 0.02%; iron, 1.2 mg
100 g-'; nicotinic acid, 0.2 mg 100 g-'; vitamin C, 600 mg 100 g-'.
The fruit also contains pectin, tannin, gallic acid and ellagic acid, in
small amounts, and glucose (Chopra et al, 1956).
Preparation of chemicals
The carcinogen 3,4-benzo(a)pyrene (C20H12, FW 252.3, CAS
registry no. [50-32-8]; Sigma, St Louis, MO, USA) was dissolved
in olive oil [Classico olive oil, Bertolli, Lucca (CEE) ITA/1173-
LtJ/20] and was administered by gastrointestinal intubation. The
concentration ofthe carcinogen used was 50 mg kg-' body weight,
observed to be clastogenic by Kliesch et al (1982). The protocol
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Table 1 Experimental protocol to study the effects of myroblan fruit against the clastogenic activity induced by 3,4-benzo(a)pyrene at different durations
Sets Treatments Concentration Dose and duration of treatment
(mg kg-' body weight)
Duration
in weeks
12 14
A A' Negative control - 28 Days
B B' Positive control 1.5 Administered in a single dose by intraperitoneal injection
C C' Vehicle control - 17 Days (thrice weekly for eight doses)
D D' Fruit extract alone 685 28 Days
E E' Fruit extract + benzo(a)pyrene - 28 Days (8 days alone + 17 days with benzo(a)pyrene thrice weekly for
eight doses + 3 days alone)
F F' Benzo(a)pyrene alone 50 17 Days (thrice weekly for eight doses)
Negative control, distilled water; positive control, mitomycin C; vehicle control, olive oil; fruit extract, crude extract of Emblic myroblan (Emblica officinalis Gaertn.)
followed was that of Wattenberg (1979) for inhibiting
benzo(a)pyrene-induced neoplasia in mice in vivo by naturally
occurring compounds.
A positive control, mitomycin C (Sigma), was dissolved in
double-distilled water at a concentration of 1.5 mgkg-' body weight
and was injected intraperitoneally to mice in a single dose 24 h
before sacrifice to test the sensitivity ofthe assay (WHO, 1985).
Animals and maintenance
Laboratory-bred male Swiss albino mice (Mus musculus, 2n = 40),
6-8 weeks of age and weighing 25-30 g, were procured from
the departmental animal house and maintained under standard
laboratory conditions (temperature 20 ±3C, relative humidity
50 ± 15% and photoperiod of 12 h). Commercial pellet diet
(Hindustan Lever, India) and distilled water were given ad libitum.
Experimental procedure
The aqueous fruit extract ofE. officinalis Gaertn. was fed daily by
gavage to two sets of mice for 8 consecutive days. From day 9,
mice of one set (Table 1, set E) were fed by gavaging 3,4-
benzo(a)pyrene on altemate days. A total ofeight doses was given
at a concentration of 5 mg ml-' ofolive oil. The crude extract was
given by gavage for a further 3 days after the final dose of 3,4-
benzo(a)pyrene, i.e. until day 28. The mice ofthe other set (set D)
were given the fruit extract alone daily for 28 days. On day 29,
mice of both sets were reverted back to commercial pellet diet.
Another set of mice (set C) was gavaged olive oil (0.2 ml per
mouse) as vehicle control by gastrointestinal intubation in eight
doses. Negative control sets received distilled water daily (set A),
and positive control sets were injected mitomycin C (set B) once,
24 h before the end of the experiment. A separate set of mice
(set F) was administered 3,4-benzo(a)pyrene alone, on altermate
days, starting from day 9 to completion ofeight doses.
Cytogenetic assays
Five mice were used for each individual set. Two replicates of the
entire experiment were carried out and mice were sacrified after a
duration of 12 weeks (sets A-F) and 14 weeks (sets A'-F').
After the final treatment, colchicine (0.04%; Sigma) was
injected intraperitoneally to each mouse 90 min before sacrifice.
Animals were then killed by cervical dislocation. Bone marrow
cells from both the femurs were flushed into 0.075 M potassium
chloride, incubated at 37°C for 15 min, re-pelleted and fixed in
cold 1:3 acetic acid-ethanol. Slides were prepared by air drying
and stained in diluted Giemsa (Preston et al, 1987; Sharma and
Sharma, 1994).
The slides were scored under code. From each animal, 100-well
scattered-metaphase plates were scanned - a total of 500 cells
from each experimental set of five mice. The types of chromo-
somal aberrations included breaks and rearrangements.
Chromosomal aberrations per cell (CA per cell) were calculated
from a total of 500 cells, regarding each chromatid break as one
break and a chromosome break or rearrangement as two breaks. In
computing the percentage ofdamaged cells (% DC), all cells with
at least one break were included.
Statistical analysis
The data were analysed using a modified Student's t-test (Fisher
and Yates, 1963) and two-way ANOVA (Sokal and Rohlf, 1987),
followed by Duncan's multiple range test (Kotz and Johnson,
1992) with the help ofHarter's table (Harter, 1960).
RESULTS
The results obtained are given in Tables 2 and 3. 3,4-
Benzo(a)pyrene, when administered alone (Table 2, sets F and F')
induced significantly high frequencies of chromosomal aberra-
tions and damaged cells after 12 weeks and 14 weeks compared
with the negative control (sets A and A'). The breaks induced were
mainly ofchromatid type, indicating damage at the S-phase ofthe
cell cycle. E. officinalis Gaertn. fruit extract, when administered
alone (sets D and D'), did not damage the cells.
Daily intubation with E. officinalis Gaertn. fruit extract before
and during exposure to the carcinogen (sets E andE'), in combined
experiments, reduced the frequencies of chromosomal aberrations
and damaged cells to a significant level when compared with the
highly clastogenic activity ofthe carcinogen alone (sets F and F').
British Journal ofCancer (1997) 76(10), 1279-1283 . CancerResearch Campaign 1997Dietarychemoprevention using Emblica officinalis Gaertn. 1281
Table 2 Alterations in chromosomal aberrations and damaged cells (in a total of 500 cells)
Chromosomal aberrations Damaged cells
Set Treatment Total CA CA percella DC%b
B' B" R (mean±s.d.) (mean±s.d.)
After 12 weeks
A Distilled water 9 - - 0.018 ± 0.00632 1.8 ± 0.63245
B Mitomycin C alone 90 2 4 0.204 ± 0.01837*** 19.2 ± 1 .03279***
C Olive oil alone 9 - - 0.018 ± 0.00632 1.8 ± 0.63245
D Extract alone 12 - - 0.024 ± 0.01837 2.4 ± 1.83787
E Extract plus carcinogen 33 - 2 0.074 ± 0.01349*** 7.0 ± 1.69967***
F Carcinogen alone 65 - 1 0.134 ± 0.02836*** 11.6 ± 2.27058***
After 14 weeks
A' Distiled water 8 - 2 0.024 ± 0.01837 2.0 ± 1.33334
B' Mitomycin C alone 95 2 6 0.222 ± 0.02573*** 18.2 ± 0.63245***
C' Olive oil alone 11 - 1 0.026 ± 0.00966 2.4 ± 0.84327
D' Extract alone 12 - 1 0.028 ± 0.01932 2.6 ± 1.89736
E' Extract plus carcinogen 45 - 2 0.098 ± 0.02394*** 9.4 ± 1.89736***
F' Carcinogen alone 69 - 4 0.154 ± 0.01646*** 12.6 ± 1 .89736***
aMean number of chromosomal aberrations per cell. bMean percentage of damaged cells. B' and B", chromatid and chromosomal
breaks (excluding gaps) respectively; R, rearrangements; CA, chromosomal aberrations; DC%, percentage of damaged cells;
***P-value significant at 0.001 level; s.d., standard deviation; carcinogen, 3,4-benzo(a)pyrene; extract, fruit extract of Emblica
officinalis Gaertn.
Table 3 Duncan's multiple range test
Distilled water Olive oil Fruit extract Fruit extract plus carcinogen Carcinogen
At 12 weeks duration
CA per cell 0.018 0.018 0.024 0.074 0.134
DC (%) 1.8 1.8 2.4 7.0 11.6
At 14 weeks duration
CA per cell 0.024 0.026 0.028 0.098 0.154
DC % 2.0 2.4 2.6 9.4 12.6
The straight lines denote insignificant difference between the means at 0 = 0.05. Fruit extract, fruit extract of Emblica officinalis Gaertn. Carcinogen,
3,4-benzo(a)pyrene.
DISCUSSION
3,4-Benzo(a)pyrene is a known genotoxic carcinogen. This
category of carcinogen functions as an electrophilic reactant, as
originally postulated by Miller and Miller (1981). The main active
group is a diol epoxide. It causes DNA damage by both direct and
indirect mechanisms. The latter involve oxygen-derived free radi-
cals (Ide et al, 1983). Chromosome aberrations, mainly chromatid
breaks, were obtained 12 and 14 weeks after the end of the treat-
ment, following the protocol of Wattenberg (1979). Such breaks
may indicate that in the haemopoietic cells, chromatid breaks may
be induced in successive cell cycles by benzo(a)pyrene, with the
potential to generate progeny with aberrant chromosomes, leading
to genomic instability and carcinogenesis. Emerit et al (1995a and
b) suggested that clastogenic factors (CFs) are released by cells
exposed to oxidative stress, which, in turn, leads to further oxyrad-
ical generation and may possibly play a role in the progressive
impairment ofblood cell-producing bone marrow and may predis-
pose patients to the development of cancer. Free radicals or reac-
tive oxygen species play an important role in the initiation and
progression of cancer.
Many radical scavengers, including naturally occurring
compounds such as vitamin C, have been found to reduce the
activity of such reactive oxygen species (Desai et al, 1996).
Another component, ellagic acid, has also been shown to protect
against DNA damage by benzo(a)pyrene (Khanduja and Majid,
1993). However, as vitamin C is present in a much higher quantity
than the other ingredients, the protective action of vitamin C was
compared with that of the crude extract. Emerit et al (1995b)
have also recommended prophylactic use of anti-oxidants against
cancer, using clastogenic plasma activity as a guide.
While screening for the protective action of plant extracts in
the diet against chromosome-damaging (clastogenic) activity of
known genotoxicants, we have shown that the crude extract gave a
higher degree of protection than its principal components. These
effects were related to the total activity ofthe crude extract, rather
than that ofa single major component (Sarkar et al, 1996).
The mostwidely usedchemopreventive agents against oral cancer
(e.g. vitamins A, E, C and beta carotene) are antioxidants/free-
radical scavengers. These antioxidants, both natural and synthetic,
inhibit the formation ofchromosome aberrations (Kada et al, 1978;
Barale etal, 1983; Enwonwu and Meeks, 1995). Vitamin C has been
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suggested to protect against cancerby inhibiting nitrosamine forma-
tion, to prevent activation ofcarcinogens, to enhance detoxification
of carcinogens, to enhance the immune response and to inhibit the
promotion phase (Machlin, 1995). The protective activity ofE. offic-
inalis Gaertn. fruit extract against 3,4-benzo(a)pyrene, shown here,
can be attributed to the combined activity ofvitamin C and the other
minor components of the fruit extract, such as ellagic acid, gallic
acid and tannins, which are known to have anti-cancer properties
(Dixit et al, 1985; Hirose et al, 1991; Fujiki et al, 1992; Sayer et al,
1993). This work is of importance, as E. officinalis Gaertn. fruit
extract can be used as a natural dietary supplement to counteract the
cytotoxic effects of exposure to the carcinogen 3,4-benzo(a)pyrene
in the initial phases.
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